FFA
IBB icon

Farther Finance Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Farther Finance Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Sell
13,147
-351
-3% -$60.3K 0.02% 641
2026
Q1 		$2.3M Buy
13,498
+4,424
+49% +$756K 0.02% 586
2025
Q4 		$1.53M Buy
9,074
+3,681
+68% +$598K 0.02% 698
2025
Q3 		$779K Buy
5,393
+88
+2% +$12K 0.01% 854
2025
Q2 		$671K Sell
5,305
-852
-14% -$105K 0.01% 765
2025
Q1 		$766K Sell
6,157
-276
-4% -$37.4K 0.02% 614
2024
Q4 		$850K Buy
6,433
+663
+11% +$93.2K 0.03% 414
2024
Q3 		$840K Buy
5,770
+2,264
+65% +$328K 0.03% 402
2024
Q2 		$480K Buy
3,506
+163
+5% +$21.8K 0.02% 492
2024
Q1 		$457K Buy
3,343
+2,236
+202% +$305K 0.03% 420
2023
Q4 		$150K Buy
1,107
+70
+7% +$8.54K 0.01% 650
2023
Q3 		$127K Buy
1,037
+554
+115% +$70.5K 0.02% 489
2023
Q2 		$61.3K Sell
483
-1,085
-69% -$141K 0.01% 600
2023
Q1 		$203K Buy
1,568
+1,300
+485% +$170K 0.06% 260
2022
Q4 		$35.2K Buy
+268
New +$34.6K 0.01% 576

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Farther Finance Advisors's IBB Position: Q2 2026 in Review

Farther Finance Advisors reduced its iShares Biotechnology ETF (IBB) stake by 2.6% in Q2 2026, selling an estimated $60.3K and leaving 13,147 shares worth $2.5M. The position accounts for 0.02% of the portfolio, ranked #641.

Farther Finance Advisors first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Farther Finance Advisors held 13,147 shares of iShares Biotechnology ETF worth $2.5M as of Q2 2026.
  • Farther Finance Advisors sold 351 iShares Biotechnology ETF shares in Q2 2026, an estimated $60.3K.
  • iShares Biotechnology ETF made up 0.02% of Farther Finance Advisors's portfolio in Q2 2026, its #641 holding.
  • Farther Finance Advisors first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.